Professor Elif Ekinci consults on diabetes and endocrinological problems including Type 1 and Type 2 diabetes, osteoporosis, PCOS, thyroid, pituitary and adrenal disease. She is a clinician scientist, an academic endocrinologist who is working to translate research into improved outcomes for people with Type 1 and Type 2 diabetes. Her research is focused on the pathophysiology, prevention, detection and treatment of diabetes and its complications in humans. She does this by undertaking observational studies and clinical trials.
She is the Weary Dunlop Medical Research Foundation Principal Research Fellow in Metabolic Medicine and Dame Kate Campbell Fellow at The University of Melbourne, Department of Medicine, Austin Health. The Dame Kate Campbell Fellowship is given to researchers recognising incredible contributions to the University of Melbourne for outstanding research and wider involvement in our local community and across the globe. She has received multiple awards for her work including Australian Diabetes Society Ranji and Amara Wikramanayake Clinical Diabetes Research Award given to the leading early-mid career diabetes researcher in Australia.
She is also the Head of Diabetes at Austin Health, where she co-ordinates the clinical care of inpatients and outpatients with diabetes. She heads diabetes and obesity clinical trials at Austin Health at the Centre for Research and Education in Diabetes and Obesity.
Professor Ekinci is the inaugural director of Australian Centre for Accelerating Diabetes Innovations (ACADI). In 2022, ACADI was established through MRFF funding from the Australian Government’s Targeted Translation Research Accelerator (TTRA) program, delivered by MTPConnect.